HEXCARE | HEXTAR HEALTHCARE BERHAD

9 9
0.080 (-5.88%)

T-O (am): 0.085 (08:59:00)
Last updated: 15:47

Fundamental
Technical
Total Score

HEXCARE | HEXTAR HEALTHCARE BERHAD

HEXCARE Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

HEXCARE Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
28 Nov 25 Q3 Sep 2025 3 31 Dec 2025 35.74 -5.40 -5.81 -16.2% 0.00 -0.53 8.8% 17.4% 36.3% 43.1%
29 Aug 25 Q2 Jun 2025 2 31 Dec 2025 39.21 -6.76 -4.26 -10.9% 0.00 -0.39 4.2% 13.5% 21.8% 70.3%
29 May 25 Q1 Mar 2025 1 31 Dec 2025 37.63 -4.11 -3.50 -9.3% 0.00 -0.32 9.7% 6.7% 56.2% 653.6%
26 Feb 25 Q4 Dec 2024 4 31 Dec 2024 41.65 -10.63 -7.99 -19.2% 0.00 -0.76 36.9% 13.7% 96.8% 83.3%
28 Nov 24 Q3 Sep 2024 3 31 Dec 2024 30.43 -5.17 -4.06 -13.3% 0.00 -0.40 11.9% 33.2% 62.3% 58.7%
29 Aug 24 Q2 Jun 2024 2 31 Dec 2024 34.54 -3.52 -2.50 -7.2% 0.00 -0.25 14.3% 14.7% 495.9% 57.6%
27 May 24 Q1 Mar 2024 1 31 Dec 2024 40.32 0.34 0.63 1.6% 0.00 0.06 10.1% 24.4% 101.3% 123.9%
26 Feb 24 Q4 Dec 2023 4 31 Dec 2023 36.64 -56.82 -47.75 -130.3% 0.00 -6.60 19.6% 8.6% 386.1% 15.3%
28 Nov 23 Q3 Sep 2023 3 31 Dec 2023 45.54 -8.17 -9.82 -21.6% 0.00 -0.98 12.5% 26.8% 66.6% 124.8%
22 Aug 23 Q2 Jun 2023 2 31 Dec 2023 40.49 -5.80 -5.89 -14.6% 0.00 -0.59 24.9% 12.7% 122.9% 386.4%
26 May 23 Q1 Mar 2023 1 31 Dec 2023 32.42 -2.32 -2.65 -8.2% 0.00 -0.26 19.1% 38.4% 95.3% 203.7%
28 Feb 23 Q4 Dec 2022 4 31 Dec 2022 40.07 -63.70 -56.38 -140.7% 0.00 -6.30 11.6% 37.6% 1190.1% 716.4%
23 Nov 22 Q3 Sep 2022 3 31 Dec 2022 35.91 -4.55 -4.37 -12.2% 0.00 -0.51 22.6% 62.2% 312.3% 117.3%
23 Aug 22 Q2 Jun 2022 2 31 Dec 2022 46.40 1.62 2.06 4.4% 0.00 0.24 11.8% 73.7% 19.3% 96.8%
31 May 22 Q1 Mar 2022 1 31 Dec 2022 52.58 3.02 2.55 4.8% 0.00 0.29 18.1% 70.0% 72.1% 97.0%
22 Feb 22 Q4 Dec 2021 4 31 Dec 2021 64.24 9.47 9.15 14.2% 0.00 1.07 32.3% 58.0% 63.7% 84.6%
26 Nov 21 Q3 Sep 2021 3 31 Dec 2021 94.90 31.35 25.22 26.6% 0.00 2.98 46.3% 13.0% 61.0% 36.2%
27 Aug 21 Q2 Jun 2021 2 31 Dec 2021 176.61 83.86 64.66 36.6% 0.00 7.78 0.8% 100.5% 25.3% 181.6%
28 May 21 Q1 Mar 2021 1 31 Dec 2021 175.24 111.92 86.57 49.4% 0.00 10.44 14.7% 163.8% 45.7% 834.8%
24 Feb 21 Q4 Dec 2020 4 31 Dec 2020 152.83 74.19 59.44 38.9% 0.00 7.41 40.2% 179.7% 50.4% 1430.7%
20 Nov 20 Q3 Sep 2020 3 31 Dec 2020 109.03 48.53 39.52 36.2% 0.00 14.88 23.8% 75.2% 72.1% 1169.0%
27 Aug 20 Q2 Jun 2020 2 31 Dec 2020 88.10 27.83 22.96 26.1% 0.00 8.69 32.6% 58.3% 147.9% 858.0%
29 Jun 20 Q1 Mar 2020 1 31 Dec 2020 66.43 10.49 9.26 13.9% 0.00 3.67 21.6% 31.7% 138.5% 372.7%
26 Feb 20 Q4 Dec 2019 4 31 Dec 2019 54.63 6.79 3.88 7.1% 0.00 1.54 12.2% 0.9% 24.7% 4367.0%
26 Nov 19 Q3 Sep 2019 3 31 Dec 2019 62.23 3.66 3.11 5.0% 0.00 1.23 11.8% 28.4% 29.9% 47.0%
27 Aug 19 Q2 Jun 2019 2 31 Dec 2019 55.64 2.67 2.40 4.3% 1.00 0.95 10.3% 47.5% 22.4% 10.2%
30 May 19 Q1 Mar 2019 1 31 Dec 2019 50.46 2.63 1.96 3.9% 0.00 0.78 6.8% 52.4% 2252.8% 34.6%
26 Feb 19 Q4 Dec 2018 4 31 Dec 2018 54.15 0.18 -0.09 -0.2% 0.00 -0.04 37.7% 54.5% 104.3% 101.6%
27 Nov 18 Q3 Sep 2018 3 31 Dec 2018 86.87 2.62 2.12 2.4% 1.00 0.84 18.1% 17.9% 20.6% 9.3%
29 Aug 18 Q2 Jun 2018 2 31 Dec 2018 106.00 3.72 2.67 2.5% 0.00 1.06 0.0% 6.2% 10.9% 11.2%
21 May 18 Q1 Mar 2018 1 31 Dec 2018 106.03 3.67 3.00 2.8% 0.75 1.19 10.9% 31.8% 47.5% 10.1%
28 Feb 18 Q4 Dec 2017 4 31 Dec 2017 118.96 4.75 5.71 4.8% 0.00 2.26 12.4% 34.7% 194.5% 39.3%
29 Nov 17 Q3 Sep 2017 3 31 Dec 2017 105.83 2.56 1.94 1.8% 1.00 0.77 6.1% 46.6% 19.2% 53.5%
21 Aug 17 Q2 Jun 2017 2 31 Dec 2017 99.77 3.56 2.40 2.4% 0.00 0.95 24.0% 31.1% 28.0% 35.9%
22 May 17 Q1 Mar 2017 1 31 Dec 2017 80.48 4.35 3.33 4.1% 0.75 1.45 8.9% 8.1% 64.6% 8.2%
24 Feb 17 Q4 Dec 2016 4 31 Dec 2016 88.32 11.45 9.40 10.6% 0.00 4.10 22.4% 11.0% 125.5% 78.7%
22 Nov 16 Q3 Sep 2016 3 31 Dec 2016 72.16 5.21 4.17 5.8% 0.50 1.82 5.2% 3.6% 11.4% 21.2%
22 Aug 16 Q2 Jun 2016 2 31 Dec 2016 76.14 4.70 3.74 4.9% 0.00 1.63 2.2% 1.3% 3.1% 14.9%
23 May 16 Q1 Mar 2016 1 31 Dec 2016 74.48 5.15 3.63 4.9% 1.50 1.58 6.4% 5.3% 31.0% 28.9%
25 Feb 16 Q4 Dec 2015 4 31 Dec 2015 79.59 6.33 5.26 6.6% 0.00 2.31 6.3% 5.6% 53.0% 341.4%
25 Nov 15 Q3 Sep 2015 3 31 Dec 2015 74.87 4.95 3.44 4.6% 1.50 1.51 0.4% 1.8% 5.6% 13.4%
25 Aug 15 Q2 Jun 2015 2 31 Dec 2015 75.17 4.70 3.26 4.3% 0.00 1.43 6.3% 1.8% 15.7% 5.4%
20 May 15 Q1 Mar 2015 1 31 Dec 2015 70.71 4.33 2.82 4.0% 1.50 1.24 6.2% 0.3% 136.3% 2.6%
27 Feb 15 31/12/14 4 31/12/14 75.36 2.05 1.19 1.6% 0.00 0.52 1.2% 8.9% 60.7% 1648.0%

HEXCARE Historical Dividends

HEXCARE Financial Ratios

EPS -1.81 sen
Trailing PE (Sector Median: 28.1) 0.0
PEG 0.0
Altman Z 1.0
Beaver 0.053
Current Ratio 6.62
Debt-Equity (DE) Ratio 0.05
FCF Yield -5.33 %
Revenue QoQ -8.84 %
Revenue YoY 17.44%
Profit QoQ -36.33 %
Profit YoY -43.08 %
Profit Margin (Sector Median: -1.1) -13.98 %
ROE (ROIC: -4.45) -4.45 %
Dividend Per Share (DPS) 0.0 sen
Dividend Yield (DY) 0.0 %

HEXCARE Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 28.1)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: -1.1)
ROE (ROIC: -4.45)
Altman Z

HEXCARE Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.44
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] -5.81
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 33.67
Expected Revenue (M) 84.81
Expected Growth (%) -10.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

HEXCARE Directors Share Purchases (Beta)


No transaction in the last 2 months.

HEXCARE Summary


Market Cap: 95 M.

Market Cap Class: Micro caps

Number of Shares: 1193 M.

Adjusted Float: 70.0%.

Stock highly correlated with

HLT (95%)

CAREPLS (94%)

D&O (86%)

MAA (86%)

Hextar Healthcare Berhad (formerly known as Rubberex Corporation (M) Berhad), incorporated in 1996 and headquartered in Malaysia, is a prominent manufacturer and distributor of rubber gloves and personal protective equipment (PPE). The company produces a wide range of gloves, including natural rubber and nitrile gloves, catering to healthcare, industrial, and food-handling sectors. Its PPE segment offers products such as face masks, protective clothing, and safety footwear, ensuring safety across diverse industries. With a strong commitment to quality, sustainability, and innovation, Hextar Healthcare continuously invests in research and development to enhance its product offerings. Supported by a global distribution network, the company serves clients across Asia, Europe, and the Americas, solidifying its reputation as a trusted partner in the healthcare and safety sectors.

Sectors: Rubber Gloves, Coronavirus, Penny Stocks, Healthcare, Health Care Equipment & Services

Share Registrar: ALDPRO CORPORATE SERVICES SDN BHD

Code: 7803

Website: https://hextarhealthcare.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

HEXCARE Top Shareholdings

Updated on 31-Mar-2023

Shareholder % Value (M)
Hextar Rubber Sdn Bhd 30.23% 28.86
Revongen Corporation Sdn Bhd 17.63% 16.83
Diamond Silk International Sdn Bhd 0.96% 0.92
Tew Seng Kiea 0.88% 0.84
Tan Chen Keong 0.6% 0.57
Zainudin Bin Karjan 0.5% 0.48
Sue Chook Keong 0.37% 0.35
Boey Tze Nin 0.37% 0.35
Kon Choi Ying 0.33% 0.32
Mok Yau Choy 0.32% 0.31
Sabri Bin Abd Hamid 0.32% 0.31
Chai Koon Khow 0.24% 0.23
Cheng Yoke Phui 0.23% 0.22
Goh Kong Wang 0.23% 0.22
METIS Equity Trust 0.23% 0.22
Ong Suan Kim 0.22% 0.21
Mok Zhi Xuan 0.2% 0.19
Samsuddin Bin Yasir 0.2% 0.19
Mohamed bin Hamzah 0.17% 0.16
Soo Yoke Mun 0.16% 0.15
Low Chu Mooi 0.16% 0.15
Goh Mooi Huan 0.16% 0.15
Raj Preet Kaur A/p Gurnam Singh 0.15% 0.14
Ping Kok Koh 0.15% 0.14
Liu Jen-Cheng 0.14% 0.13
Yap Sim Yee 0.14% 0.13
Khoo Chin Leng 0.01% 0.0
Frequently Asked Questions
Hextar Healthcare Berhad (formerly known as Rubberex Corporation (M) Berhad), incorporated in 1996 and headquartered in Malaysia, is a prominent manufacturer and distributor of rubber gloves and personal protective equipment (PPE). The company produces a wide range of gloves, including natural rubber and nitrile gloves, catering to healthcare, industrial, and food-handling sectors. Its PPE segment offers products such as face masks, protective clothing, and safety footwear, ensuring safety across diverse industries. With a strong commitment to quality, sustainability, and innovation, Hextar Healthcare continuously invests in research and development to enhance its product offerings. Supported by a global distribution network, the company serves clients across Asia, Europe, and the Americas, solidifying its reputation as a trusted partner in the healthcare and safety sectors. The company is listed on Bursa Malaysia and operates in the Rubber Gloves, Coronavirus, Penny Stocks, Healthcare and Health Care Equipment & Services sectors.
Yes, HEXTAR HEALTHCARE BERHAD is listed as Shariah-compliant.
The latest share price of HEXTAR HEALTHCARE BERHAD is RM 0.080 updated on 22 January 2026 15:47.
As of now, HEXTAR HEALTHCARE BERHAD has a market capitalization of 95M based on the latest financial data.
iSaham's technical analysis indicates that HEXTAR HEALTHCARE BERHAD's support level is at RM 0.08 and its resistance level is at RM 0.095, based on moving averages and price patterns.
The 52-week high for HEXTAR HEALTHCARE BERHAD is RM 0.095
HEXTAR HEALTHCARE BERHAD's share price has decreased by -54.29% year-to-date, influenced by market trends and company performance.
Dividend information for HEXTAR HEALTHCARE BERHAD has not been reported yet. Track HEXTAR HEALTHCARE BERHAD's upcoming dividend announcements, yield changes, and payout history easily with the iSaham Stock Screener.
The main shareholders of HEXTAR HEALTHCARE BERHAD include Hextar Rubber Sdn Bhd, Revongen Corporation Sdn Bhd and Diamond Silk International Sdn Bhd. View more on HEXTAR HEALTHCARE BERHAD Top Shareholders page.
You can buy HEXTAR HEALTHCARE BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.